Skip to main content
Premium Trial:

Request an Annual Quote

Genospectra Raises $16.4M in Series C Financing

NEW YORK, Sept. 14 (GenomeWeb News) - Genospectra has raised $16.4 million in a Series C financing round, the company said today.


Fremont, Calif.-based Genospectra plans to use the funding to develop cell-based assays and a quantitative cell-based method for gene expression profiling.


Batelle Ventures led the financing round. New investors were Agilent Ventures, 5AM Ventures, Aravis Ventures, Allen, and private investors. They were joined by existing investors Alex Zaffaroni, Frazier Healthcare Ventures, HBM Bioventures, Novartis Bioventures, Bio*One Capital, Bay City Capital, and Affymetrix.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.